Radoslaw Janiak
Chief Executive Officer at Future Meds Ltd.
Profile
Radoslaw Janiak currently works at Future Meds Ltd., as Chief Executive Officer from 2019, Synexus Clinical Research GmbH, as Co-Managing Director, and Synexus Clinical Research Ltd., as President & Chief Operating Officer from 2017.
Radoslaw Janiak active positions
Companies | Position | Start |
---|---|---|
Synexus Clinical Research Ltd.
Synexus Clinical Research Ltd. Medical/Nursing ServicesHealth Services Synexus Clinical Research Ltd. offers clinical trials and biological research services. It offers clinical trial management, project management, medical imaging and medical procedures. The company was founded in 1998 and is headquartered in Lancashire, the United Kingdom. | President | 2016-12-31 |
Synexus Clinical Research GmbH
Synexus Clinical Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Thermo Fisher Scientific, Inc., Synexus Clinical Research GmbH is a clinical research organization based in Leipzig, Germany. The CEOs are Radoslaw Janiak, Marcin Gondek, Iwona Tongbhoyai. The German company was founded in 1992. Synexus Clinical Research was acquired by Synexus Clinical Research Ltd., part of Thermo Fisher Scientific, Inc. from June 08, 2016 on January 12, 2010. | Chief Executive Officer | - |
Future Meds Ltd.
Future Meds Ltd. Miscellaneous Commercial ServicesCommercial Services Future Meds Ltd. is a fast-growing independent research site network that supports pharmaceutical companies, sponsors, and CROs in finding effective treatments and medications for patients. The private company is based in Bromborough, UK, and has subsidiaries in Germany and the United Kingdom. The British company's dedicated research site teams aim to accelerate study timelines, streamline processes, lower costs, and improve data quality to help patients access new treatments faster. Future Meds is a network of modern dedicated research sites that conduct clinical trials using innovative technologies to make them available to as many patients as possible. The company was founded in 2020, and Radoslaw Janiak has been the CEO since 2019. | Chief Executive Officer | 2019-09-30 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Synexus Clinical Research Ltd.
Synexus Clinical Research Ltd. Medical/Nursing ServicesHealth Services Synexus Clinical Research Ltd. offers clinical trials and biological research services. It offers clinical trial management, project management, medical imaging and medical procedures. The company was founded in 1998 and is headquartered in Lancashire, the United Kingdom. | Health Services |
Synexus Clinical Research GmbH
Synexus Clinical Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Thermo Fisher Scientific, Inc., Synexus Clinical Research GmbH is a clinical research organization based in Leipzig, Germany. The CEOs are Radoslaw Janiak, Marcin Gondek, Iwona Tongbhoyai. The German company was founded in 1992. Synexus Clinical Research was acquired by Synexus Clinical Research Ltd., part of Thermo Fisher Scientific, Inc. from June 08, 2016 on January 12, 2010. | Commercial Services |
Future Meds Ltd.
Future Meds Ltd. Miscellaneous Commercial ServicesCommercial Services Future Meds Ltd. is a fast-growing independent research site network that supports pharmaceutical companies, sponsors, and CROs in finding effective treatments and medications for patients. The private company is based in Bromborough, UK, and has subsidiaries in Germany and the United Kingdom. The British company's dedicated research site teams aim to accelerate study timelines, streamline processes, lower costs, and improve data quality to help patients access new treatments faster. Future Meds is a network of modern dedicated research sites that conduct clinical trials using innovative technologies to make them available to as many patients as possible. The company was founded in 2020, and Radoslaw Janiak has been the CEO since 2019. | Commercial Services |
- Stock Market
- Insiders
- Radoslaw Janiak